1
THE HORSEMAN
EXT. POONAWALLA STUD FARM, PUNE — DAY — 1960
Rolling green hills outside Pune, India. Thoroughbred horses graze in manicured paddocks. CYRUS POONAWALLA, 19, watches them with the eye of a man who understands breeding, bloodlines, and the patience required to produce excellence.
CYRUS POONAWALLA
My father built the finest stud farm in India. I was supposed to continue it. Raise horses. Win races. Live well. That was the plan.
He walks to the stable. A horse has been retired from racing and is being prepared for a different purpose — its blood will be used to produce anti-tetanus serum. The Haffkine Institute in Mumbai uses horse serum to make vaccines. Cyrus watches the veterinarian draw blood.
CYRUS POONAWALLA
((to the veterinarian))
How much do they pay you for the serum?
VETERINARIAN
((O.S.))
A few hundred rupees per horse. It's nothing compared to racing.
Cyrus says nothing. But he's calculating. Not the money — the math of need. India has 500 million people. Most have never been vaccinated against anything.
INT. POONAWALLA FAMILY HOME — NIGHT — 1966
CYRUS sits at a large dining table with his family. He has been reading about the global vaccine market obsessively. Reports from the WHO. Papers on immunization in developing countries. The numbers haunt him.
CYRUS POONAWALLA
Every year, millions of children in India die from diseases that have been preventable for decades. Measles. Tetanus. Diphtheria. The vaccines exist — but they cost too much for India to afford. The Western companies charge ten, twenty, fifty times what it costs to produce.
His family exchanges glances. Cyrus is a horse breeder, not a doctor.
CYRUS POONAWALLA
I know what you're thinking. But I understand biology. I understand breeding. I understand production at scale. And I have the horses.
The connection was audacious but logical. Vaccines were traditionally produced using horse serum. Cyrus Poonawalla had the largest stud farm in India. He had the raw material, the land, and the ambition. What he didn't have was a medical degree. He didn't need one.
2
SERUM INSTITUTE
INT. CONVERTED HORSE STABLE, PUNE — DAY — 1966
SERUM INSTITUTE OF INDIA IS FOUNDED
A horse stable has been converted into a rudimentary laboratory. Equipment is basic. The floor is still hay-strewn in places. CYRUS walks through with DR. RABIA HUSSAIN, a newly hired virologist.
DR. HUSSAIN
Mr. Poonawalla, with all respect — this is a stable.
CYRUS POONAWALLA
It was a stable. Now it's a vaccine factory. The world's most important vaccine factory. They just don't know it yet.
DR. HUSSAIN
We don't have WHO prequalification. No government contracts. No distribution network. We have horses and a dream.
CYRUS POONAWALLA
We have something the Western companies don't: a reason to charge less. Pfizer makes vaccines to make money. We will make vaccines to save lives. The money will follow.
INT. SERUM INSTITUTE PRODUCTION LINE — DAY — 1970
The facility has grown. Proper clean rooms. Modern equipment. CYRUS walks the production line. Anti-tetanus serum flows through tubes into vials. The production cost is a fraction of what Western companies charge.
CYRUS POONAWALLA
We sell a dose for one-tenth the price of European manufacturers. One-tenth. And we still make a profit. Because our costs are lower. Our labor is cheaper. Our motivation is different.
INT. WHO HEADQUARTERS, GENEVA — DAY — 1987
CYRUS sits across from a WHO OFFICIAL. Serum Institute has been producing vaccines for twenty years but needs WHO prequalification to sell to international organizations — UNICEF, GAVI, the WHO itself.
WHO OFFICIAL
Mr. Poonawalla, your prices are remarkable. But we need assurance of quality. Your facility is in Pune, not Basel or New Jersey.
CYRUS POONAWALLA
Visit Pune. See the facility. Test the product. You will find that geography has nothing to do with quality.
The WHO inspects Serum Institute. They find a world-class operation — clean, modern, producing millions of doses at costs that make European executives nervous.
SERUM INSTITUTE RECEIVES WHO PREQUALIFICATION
EXT. RURAL INDIAN VILLAGE — DAY — 1990s
A health worker administers vaccines to children in a dusty village. The vials are marked: SERUM INSTITUTE OF INDIA. An INDIAN MOTHER holds her child.
INDIAN MOTHER
((in Hindi, subtitled))
My mother lost three children to measles. Three. Now my children will live.
The health worker moves to the next child. Then the next. Then the next. Serum Institute vaccines flow through government programs across India, Africa, Southeast Asia — reaching the poorest corners of the world.
By the mid-1990s, Serum Institute of India was vaccinating roughly two out of every three children born on Earth. Not because it was famous. Not because it was flashy. Because its vaccines cost pennies and worked just as well as those costing dollars.
3
THE NEXT GENERATION
INT. SERUM INSTITUTE BOARDROOM — DAY — 2011
ADAR POONAWALLA, Cyrus's son, 30, sits beside his father. He has been groomed to take over. Educated in London, sharp, ambitious, and even more aggressive about growth.
ADAR POONAWALLA
Father, we produce 1.5 billion doses a year. We supply over 170 countries. But we're still seen as a generic manufacturer. I want us to develop our own vaccines. Original research. Novel formulations.
CYRUS POONAWALLA
We have always been underestimated. Good. Let them underestimate us. While they're looking down, we vaccinate the world.
ADAR POONAWALLA
I want more. I want them to look up.
INT. GATES FOUNDATION OFFICES — DAY — 2013
BILL GATES sits across from CYRUS and ADAR. The Gates Foundation has been Serum Institute's partner for years, funding vaccine distribution across Africa.
BILL GATES
Cyrus, your institute saves more lives per dollar than almost any organization on Earth. What you've built is extraordinary.
CYRUS POONAWALLA
Thank you, Bill. But we need to prepare for the next pandemic. Not if — when. And when it comes, the world will need billions of doses in months, not years.
BILL GATES
You think you can scale that fast?
CYRUS POONAWALLA
We already produce 1.5 billion doses a year. We just need to pivot to whatever the pathogen is. Speed and scale — that's what we do.
4
THE PANDEMIC
INT. SERUM INSTITUTE, PUNE — DAY — MARCH 2020
COVID-19 PANDEMIC
Alarms are metaphorical but the urgency is real. ADAR stands in the production facility. COVID-19 is spreading across the world. No vaccine exists yet. But Serum Institute is already preparing.
ADAR POONAWALLA
We're going to start manufacturing AstraZeneca's vaccine before it's approved. Before clinical trials are done. We're going to produce hundreds of millions of doses at risk. If the vaccine works, we save six months of production time. If it doesn't, we lose hundreds of millions of dollars.
DR. HUSSAIN
That's an enormous gamble.
ADAR POONAWALLA
People are dying. The gamble is not producing them.
INT. SERUM INSTITUTE PRODUCTION FLOOR — DAY — JANUARY 2021
COVISHIELD APPROVED — SERUM INSTITUTE BEGINS MASS DISTRIBUTION
The production floor is a cathedral of stainless steel and glass. Thousands of workers in cleanroom suits. Vials roll off production lines by the millions. CYRUS, now 80, walks the floor with ADAR.
CYRUS POONAWALLA
When I started this company, it was in a horse stable. Now look.
ADAR POONAWALLA
We're producing 70 million doses a month. India, Africa, South America — everyone who can't afford Pfizer comes to us.
CYRUS POONAWALLA
That was always the point. Not the richest customers. The most important ones.
EXT. VACCINATION CENTER, MUMBAI — DAY — 2021
A massive vaccination center. Hundreds of people line up. Each receives Covishield — Serum Institute's version of the AstraZeneca vaccine. The vials are familiar — same simple label, same commitment to accessibility.
Serum Institute of India produced over 1.5 billion doses of Covishield during the pandemic. At $3 per dose — compared to $20 for Pfizer and $15 for Moderna — it became the vaccine of the developing world. More than half of all COVID vaccines administered globally came from Serum Institute of India. A horse breeder's stable in Pune had become the most important pharmaceutical facility on Earth.
INT. POONAWALLA ESTATE, PUNE — EVENING — PRESENT
CYRUS, now in his 80s, sits on the veranda of his estate. The stud farm is still operational — horses still graze in the paddocks. But beyond the fields, the Serum Institute campus sprawls across 100 acres, a gleaming complex of laboratories, production facilities, and research centers.
CYRUS POONAWALLA
They call me the Vaccine King. I don't like titles. But if that title means that children in Africa and India and Southeast Asia live instead of die — then I'll wear it.
A horse whinnies in the distance. Cyrus smiles.
CYRUS POONAWALLA
It all started with the horses. Everything always starts with something unexpected. You just have to be paying attention.
The sun sets over Pune. The production lines inside Serum Institute continue to run. They never stop. Somewhere in the world, a child receives a vaccine that costs three cents to produce. That child will live.
Serum Institute of India produces over 1.5 billion vaccine doses annually — more than any other facility on Earth. Cyrus Poonawalla's net worth exceeds $20 billion, making him one of India's richest people. He has been awarded the Padma Bhushan, India's third-highest civilian honor. His son Adar continues to expand the institute's capabilities. The horses still run at the Poonawalla Stud Farm. And every year, two out of three children born on this planet receive at least one vaccine made in Pune.
FADE OUT.